Day: November 20, 2024

HARRISBURG, Pa., Nov. 20, 2024 (GLOBE NEWSWIRE) — Ollie’s Bargain Outlet Holdings, Inc. (NASDAQ: OLLI) (the “Company”) announced today that it will release its financial results for the third quarter of fiscal year 2024 on Tuesday, December 10, 2024, before the market opens. Following the release, at 8:30 a.m. Eastern Time, the Company’s management team will host a conference call to discuss its results. To access the live conference call, please pre-register here. Registrants will receive a confirmation with dial-in instructions. Interested parties can also listen to a live webcast or replay of the conference call by logging on to the Investor Relations section on the Company’s website at https://investors.ollies.us/. About Ollie’sWe are America’s largest retailer of closeout merchandise and excess inventory, offering Real Brands...

TUSCANY study is open to enroll patients to receive TUS+VEN+AZA triplet at select US sites Favorable safety and broad clinical activity make tuspetinib an ideal agent to combine with venetoclax and azacitidine to potentially address larger AML populations Study execution update is expected during ASH 2024SAN DIEGO and TORONTO, Nov. 20, 2024 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company developing highly differentiated oral targeted agents to treat hematologic malignancies, today announced initiation of the TUSCANY study, tuspetinib (TUS) in combination therapy with azacitidine (AZA) and venetoclax (VEN) as a frontline triplet combination therapy for patients newly diagnosed with acute myeloid leukemia, or AML. The trial is being conducted...

TORONTO, Nov. 20, 2024 (GLOBE NEWSWIRE) — Golconda Gold Ltd. (“Golconda Gold” or the “Company”) (TSX-V: GG; OTCQB: GGGOF) announces that its Chief Executive Officer, Nicholas Brodie, will be retiring as CEO and a director of Golconda Gold on November 30, 2024. We are pleased to announce that Ravi Sood, Golconda Gold founder, Executive Chairman, and former CEO, will replace Mr. Brodie as Chief Executive Officer effective November 30, 2024. Mr. Sood has been the Executive Chairman of Golconda Gold since its inception and previously served as its Chief Executive Officer from October 2013 to November 2014. Mr. Sood is an accomplished executive and investor having been the CEO of Navina Asset Management Inc., an investment management firm responsible for a variety of mandates that was acquired in 2009. Mr. Sood has also been an investor,...

ALMATY, Kazakhstan, Nov. 20, 2024 (GLOBE NEWSWIRE) — Joint Stock Company Kaspi.kz (Nasdaq: KSPI) announces that the following resolutions were duly passed at its Extraordinary General Meeting on 19 November 2024:To approve the agenda of the Extraordinary General Meeting of Shareholders of JSC Kaspi.kz:1) Approval of the agenda;2) Payment of dividends on common shares of JSC Kaspi.kz and approval of the amount of dividend per common share;3) Approval of amended Charter of JSC Kaspi.kz;4) Election of the Board Member due to resignation of one of the Board Members;5) Approval of the amount and terms of remuneration and reimbursement of expenses of the Board Members incurred while performing Board Member’s duties;6) On entering into a major transaction (and the Company’s participation in the activities of a legal entity),...

Hoerter Brings Over Three Decades of Oncology Commercialization and Leadership Experience Appointment Underscores Continued Transformation of Board to Lead C4T into Next Phase of Pipeline Progress WATERTOWN, Mass., Nov. 20, 2024 (GLOBE NEWSWIRE) — C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, today announced the continued evolution of its Board of Directors with the appointment of Steve Hoerter as a director. “Our commitment to assembling a group of industry experts who offer diverse perspectives to our Board has resulted in bringing on some of the industry’s brightest minds, from leaders in asset discovery, to discovery, clinical development and corporate governance experts. As we continue advancing our portfolio of novel degraders,...

The Base Shelf Prospectus is accessible, and the Prospectus Supplement will be accessible within two business days, through SEDAR+ VANCOUVER, British Columbia, Nov. 20, 2024 (GLOBE NEWSWIRE) — Endeavour Silver Corp. (“Endeavour” or the “Company”) (NYSE: EXK; TSX: EDR) is pleased to announce that it has entered into an agreement with a syndicate of underwriters (the “Underwriters”) led by BMO Capital Markets, pursuant to which the Underwriters have agreed to buy on a bought-deal basis 15,825,000 common shares of the Company (the “Common Shares”), at a price of US$4.60 per Common Share for aggregate gross proceeds of approximately US$73 million (the “Offering”). The Company has granted the Underwriters an option, exercisable in whole or in part for a period of 30 days following the closing of the Offering,...

Preparation for drilling is underway at two priority porphyry target areas that have been defined and supported by coincident geological, geophysical, geochemical and alteration attributes At Sobek North, to refine final drill collar positioning ground based electrical geophysics is being conducted at the Potro SE target located 3 km from NGEx´s Lunahuasi discovery At Sobek Central, road construction to facilitate geochemical sampling, ground geophysics and drilling is in progress to improve access to a trend of porphyry targets that start at the VN-Zone and extends south for at least 3 km to the Sobek 46 South target The VN-Zone is located on a parallel north-south structural trend 7 km directly west of Filo Mining’s Filo del Sol ProjectVANCOUVER, British Columbia, Nov. 20, 2024 (GLOBE NEWSWIRE) — Mirasol Resources Ltd. (TSX-V:...

NEW YORK, Nov. 20, 2024 (GLOBE NEWSWIRE) — WeRide (Nasdaq: WRD), the leading global commercial-stage company developing autonomous driving technologies from Level 2 to Level 4, announced that its Robosweeper S6 and Robosweeper S1 have officially commenced operations at Marina Coastal Drive and Esplanade in Singapore, respectively. This milestone represents Singapore’s first commercialized autonomous sanitation project, setting a benchmark for the broader adoption of smart sanitation technologies in the country. The commercial launch of WeRide’s two autonomous sanitation devices follows one week after the company’s receipt of M1 and T1 licenses from the Land Transport Authority of Singapore (LTA), highlighting WeRide’s exceptional execution capabilities and industry-leading speed in advancing global commercialization. In...